All posts by imreal

Health: Addiction

Top Rated Physical Therapy Group Secures Partnership with University of Louisville Athletics

Leave a comment


“We are delighted to be partnering with Louisville Athletics for the upcoming athletic season,” said PRPT’s CEO, Pat Wempe, PT, DPT, SCS, CSCS. “We look forward to our association with exceptional student athletes who embody the same values that are important to our company – working hard and having fun.”

With over 15 physical therapy practices across Kentucky, PRPT prides itself on delivering the best care and results to its patients through proven research, innovative treatments and technologies. This, along with a longstanding business relationship with Confluent Health, a Louisville-based family of physical and occupational therapy companies spanning the nation, and shared management services associated with it, PRPT is considered one of Kentucky’s top rated physical and occupational therapy experts.

CEO of Confluent Health, Dr. Kristi Henderson, DNP, FAAN, also expressed her enthusiasm for the partnership, stating, “We are excited to see ProRehab Physical Therapy collaborate with University of Louisville Athletics. The partnership aligns perfectly with our mission to positively impact the communities we serve by delivering best-in-class musculoskeletal care and advancing physical therapy practices through evidence-based research.”

In addition, Founder and Executive Chairman of Confluent Health, Dr. Larry Benz, PT, DPT, OCS, MBA, MAPP, FAPTA, has a rich history with the University of Louisville having served in multiple past and current roles with the University of Louisville’s Board of Trustees. Dr. Benz’s deep involvement with the university and its athletic association infuses this partnership with a sense of shared history and potential.

“The partnership between ProRehab Physical Therapy and University of Louisville Athletics has created a power team between top-tier physical therapists and top-performing collegiate athletes,” added Dr. Benz. “I am confident in PRPT’s top-notch care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. I could not be more thrilled to watch the partnership between PRPT and UofL bloom.”

To learn more about PRPT or to book a free consultation with one of Kentucky’s experts in physical therapy, please visit prorehab.com. 
About ProRehab Physical Therapy: ProRehab Physical Therapy (PRPT) is a Kentucky-based, private physical therapy practice group. As a proud member of the Confluent Health family, PRPT positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit prorehab.com, or find them on Facebook at @prorehablou.

About Confluent Health: Confluent Health is a family of physical and occupational therapy companies. We are transforming healthcare by strengthening private practices, developing highly effective clinicians, innovating new services and technology to improve the quality of care for patients, and lowering costs via more effective treatment, workplace wellness, and injury prevention. For more information, visit goconfluent.com or find us on Facebook at @confluenthealth.

Media Contact

Samantha Grimsley, Confluent Health, 502-472-9674, [email protected], https://goconfluent.com/

SOURCE Confluent Health

Health

Neurotech wellness company Roga partners with major Indian telehealth company

Leave a comment


$35 Million Contract Marks First International Deal & First Healthcare Partnership for the Wearable Pioneer

SAN DIEGO, Aug. 23, 2023 /PRNewswire-PRWeb/ — Neurotech wellness company Roga announced today that it has partnered with GlobalSpace Technologies Ltd. (“GlobalSpace”), India’s first telehealth company, with a $35 million contract. This signals the first major healthcare deal for Roga, as well as its official global expansion beyond the U.S.

Earlier this year, Roga announced it would begin its B2B corporate partnerships program to provide the Roga stress-relief platform to a company’s employees as part of its benefits packages. In addition, Roga also launched its D2C offering in late 2022; consumers in the U.S. can purchase a Roga device directly from the company and download the companion app on iPhones and Androids.

In partnering with GlobalSpace however, Roga is now making its foray into offering white-label services to healthcare companies worldwide to provide the Roga platform to patients directly. While this deal is the first such healthcare partnership for Roga, CEO Ami Lebendiker says this is part of the company’s strategic vision and will be the first of many partnerships. It also marks Roga’s strategic expansion beyond the U.S. market.

“Partnering with healthcare providers and companies has always been part of Roga’s vision, as has been making our devices available to people outside the U.S.,” said Lebendiker. “Stress is a global epidemic. Poor mental health is affecting people’s quality of life around the world. We intend to be able to help people wherever they are, and today’s partnership with one of the leading telehealthcare companies in India is a step in that direction.”

According to a 2017 study, some 44.9 million people in India were reported to be suffering from anxiety related mental health issues, while a 2020 study reported 88% of all Indians suffering from stress and 88% from anxiety. Yet the country was shown to have just 0.75 psychiatrists per 100,000 people. Telehealth has been touted as a critical part of the solution by connecting people to care via their mobile devices – hence a mobile device like Roga can be a benefit.

The Roga device plugs into any phone and runs on the accompanying app, so users can use it anytime they need it. The wearable device sits behind the ears like a pair of headphones and emits a gentle electrical signal that targets the brain’s fight-or-flight response and encourages alpha brain waves, which are associated with calm focus.

Because Roga is mobile, easy-to-use, and low-cost, it is therefore more accessible to the general population, particularly for those who may not have easy access to other forms of mental health support.

“As a telehealth innovator in India, GlobalSpace and Roga were aligned on our core values of providing care in a convenient, accessible, and cutting-edge way that allows us to reach more people wherever they are,” said GlobalSpace Technologies Ltd. CEO Krishna Singh.

GlobalSpace’s DocExa platform is used by over 50,000 healthcare professionals (HCPs) who serve thousands of patients daily dealing with high levels of stress and anxiety. DocExa helps HCPs manage appointments and medical records. It also offers patients a virtual talk therapy program which was designed to help alleviate the issue of access to mental health professionals in India.

Under the agreement, GlobalSpace and Roga will create a new platform called GoRoga, an exclusive for India, that combines the DocExa offerings with Roga’s devices. With GoRoga, HCPs will be able to refer their patients to the Roga device in addition to their existing tools. Because Roga targets the physiological symptoms of stress, this can help complement talk therapy and other methods to create a more well-rounded approach to supporting patients’ mental health. This means patients will be able to access physician care, virtual talk therapy, and the Roga device, all through the GoRoga platform on their phones.

More broadly, GlobalSpace and Roga are partnering to create an ecosystem to promote mental health and wellness in India, assisting patients in managing stress and anxiety, tracking their progress, and engaging in holistic mental wellness practices.

“We’re so proud to be able to partner with GlobalSpace on this effort,” added Lebendiker. “We’re confident this can help meaningfully improve quality of life for a lot of people in India and around the world, and we’re thrilled to see it coming to fruition.”

About Roga:

Roga is a mental health and wellness company using the latest in Neurotech and AI to relieve severe stress and burnout in a convenient, cost-effective way. Based in San Diego and Toronto, Roga was founded in 2020 and launched its inaugural product in 2022. The Roga Life™ is a paired wearable/app duo that combines two proven methods – peripheral nerve stimulation and personalized guided meditations into one safe, effective, and affordable solution. Roga is a VC funded startup and has received multiple research grants.

About GlobalSpace Technologies Ltd.:

GlobalSpace Technologies Ltd. being the thought leaders in pharma digital solutions plays a deep and meaningful role in powering the future of healthcare. We partner with Global and India’s leading life sciences organizations to help them navigate the intricacies of a rapidly converging healthcare industry. With end-to-end offerings across consulting, healthcare solutions, products and digital marketing solutions we empower organizations to optimize their business by leveraging technology and keeping pace with changing environments. Our exclusive focus on the healthcare and life sciences markets enables us to offer domain-centric solutions, services and platforms to our clients that are business focused and outcome based.

Media Contact

Hannah Golden, Roga, 1 (510) 817 – 2218, [email protected], www.rogalife.com

SOURCE Roga

Science: Biology

PREDICTif Solutions Attains AWS (Amazon Web Services) Advanced Tier Services Partner Status, Reinforcing Market Leadership and Commitment to Customer Success

Leave a comment


“This recognition is a testament to the hard work and dedication of our entire team, as well as the trust and support of our valued clients. We remain committed to pushing the boundaries of innovation and achieving joint success with AWS, ” Jeff Huang, CEO at PREDICTif Solutions.

This achievement confirms PREDICTif Solutions as an exceptional choice for organizations seeking best-in-class analytics, machine learning, and artificial intelligence solutions on the AWS platform. Customers can confidently choose PREDICTif Solutions, knowing they are partnering with an industry leader recognized for its excellence.

“We’re excited about the value this achievement brings to our clients,” added Todd Perrine, Chief Revenue Officer. “With our AWS Advanced Tier status, we can provide our customers with greater access to resources, expertise, and unique investment programs.

PREDICTif Solutions’ attainment of AWS Advanced Tier Services Partner status signifies more than just recognition—it embodies a promise to its customers, employees, and partners.

About PREDICTif Solutions

PREDICTif Solutions is a leading provider of advanced analytics, machine learning, and artificial intelligence solutions, with a strong commitment to delivering exceptional results for clients. As an AWS Advanced Tier Services Partner, PREDICTif is dedicated to innovation, customer success, and pushing the boundaries of what’s possible within the cloud computing landscape. With an unwavering focus on excellence, PREDICTif empowers organizations to achieve their goals through cutting-edge technology and transformative solutions.

###

Media Contact

Todd Perrine, PREDICTif, +1 512.777.9791, todd.perrine@predictifsolutions.com

SOURCE PREDICTif

Technology: Computer

Kerr Surveying Ranks No. 3803 on the 2023 Inc. 5000

Leave a comment


– Nathan Kerr, President

www.kerrlandsurveying.com

The Inc. 5000 class of 2023 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges. Among this year’s top 5000 companies, the average median three-year revenue growth rate ticked up to an astonishing 2,238 percent. In all, this year’s Inc. 5000 companies have added 1,187,266 jobs to the economy over the past three years.

For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, go to www.inc.com/inc5000. The top 500 companies are featured in the September issue of Inc. magazine, available on newsstands beginning Wednesday, August 23.

“Running a business has only gotten harder since the end of the pandemic,” says Inc. editor-in-chief Scott Omelianuk. “To make the Inc. 5000—with the fast growth that requires—is truly an accomplishment. Inc. is thrilled to honor the companies that are building our future.”

“While it is an amazing recognition to be one of the 5,000 fastest growing companies in the nation, the real recognition goes to our team. It is solely because of their belief in our vision, faith in our leadership, and countless hours spent putting in the hard work that we have achieved this honor. “

– Eric Bryant, Vice President

www.kerrlandsurveying.com

Founded in 1986 by Brad Kerr, Kerr Surveying has a rich and storied history serving and surveying the greater Brazos Valley and more recently, the great State of Texas. Kerr’s original office location was off Church Street in the historic Northgate District of College Station, TX. In 2011, as the business continued to grow and scale, Kerr Surveying moved to its current office location of 409 N. Texas Avenue, Bryan, TX. In 2020, following in his father’s footsteps, Nathan Kerr purchased Kerr Surveying from his father, Brad Kerr. Since then, Kerr Surveying has more than doubled its staff, expanded its geographic service area across the state of Texas and experienced exponential growth.

CONTACT:
Eric Bryant
[email protected]
www.kerrlandsurveying.com

More about Inc. and the Inc. 5000

Methodology

Companies on the 2023 Inc. 5000 are ranked according to percentage revenue growth from 2019 to 2022. To qualify, companies must have been founded and generating revenue by March 31, 2019. They must be U.S.-based, privately held, for-profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2022. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2019 is $100,000; the minimum for 2022 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to four decimal places.

About Inc.

Inc. Business Media is the leading multimedia brand for entrepreneurs. Through its journalism, Inc. aims to inform, educate, and elevate the profile of our community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating our future. Inc.’s award-winning work reaches more than 50 million people across a variety of channels, including events, print, digital, video, podcasts, newsletters, and social media. Its proprietary Inc. 5000 list, produced every year since 1982, analyzes company data to rank the fastest-growing privately held businesses in the United States. The recognition that comes with inclusion on this and other prestigious Inc. lists, such as Female Founders and Power Partners, gives the founders of top businesses the opportunity to engage with an exclusive community of their peers, and credibility that helps them drive sales and recruit talent. For more information, visit www.inc.com.

SOURCE Kerr Surveying, LLC

Society: Social Services

OSHA Outreach Courses Introduce Buy Now Pay Later To Make Workplace Safety More Accessible

Leave a comment


“Our aim is to make sure everyone has access to workplace certifications and we believe this move will go a long way in helping us achieve this goal,” says Farhan Siraj, Co-Founder and CEO of OSHA Outreach Courses. “Learners with budgetary constraints will benefit a great deal from this flexible payment model,” he emphasizes.

Interest Free Payments With Zero Additional Charges

Similar to how BNPL mode of payment is applied in other settings, OSHA Outreach Courses will not charge any interest payments from the learners. There will be no additional fee as long as the payments are made on the scheduled time. “You will still pay the same amount but the payments will be divided into equal monthly installments,” explains Farhan.

Smooth Verification Process

BNPL programs by different businesses often have a long and strenuous verification process. However, OSHA Outreach Courses has applied a painless process to verify those who wish to enroll in the OSHA 10 & OSHA 30 courses. The platform enforces a simple three step procedure to ensure that individuals can swiftly access the benefits of our payment flexibility.

Making OSHA Certifications Easily Attainable

Financial constraints often act as huge barriers, stopping people from getting OSHA certifications that will enhance their knowledge of workplace safety and improve their career prospects. OSHA Outreach Courses believes a limited budget shouldn’t come between workers and their aspirations to achieve professional growth.

About OSHA Outreach Courses

OSHA Outreach Courses is a platform that provides workplace safety training solutions to employers and employees across different industries. It’s a one-stop online learning platform for contractors, manufacturers and manual workers to empower themselves with critical knowledge on workplace safety.

For additional information, visit https://www.oshaoutreachcourses.com/ or call +1-833-212-6742. You can also email the company at [email protected].

Media Contact

Farhan Siraj, OSHA Outreach Courses, 1 833-212-6742, [email protected], https://www.oshaoutreachcourses.com/

Twitter, LinkedIn

SOURCE OSHA Outreach Courses



health and fitness

Boston IVF Welcomes Reproductive Endocrinologist Ann Korkidakis, MD to its Waltham & Worcester Fertility Center Teams

Leave a comment


The addition of Dr. Ann Korkidakis to Boston IVF and its Massachusetts fertility centers in Worcester and Waltham bolsters the availability of prompt reproductive care for individuals aspiring to create a family.

WALTHAM, Mass., Aug. 22, 2023 /PRNewswire-PRWeb/ — Boston IVF, one of the world’s most experienced fertility treatment providers, which has assisted in over 150,000 babies born since 1986, is pleased to announce that reproductive endocrinologist, Ann Korkidakis, MD has joined its practice and physician team.

Dr. Korkidakis is now accepting new patients at all of Boston IVF’s fertility centers in Massachusetts via telemedicine and in person at the Worcester and Waltham, Massachusetts locations. She specializes in a comprehensive array of infertility treatments and family building services, including, intrauterine insemination (IUI), in vitro fertilization (IVF), egg freezing, LGBTQ+ family building services, recurrent pregnancy loss, PCOS, and more.

Her current research interests include early embryo development, recurrent pregnancy loss, and ongoing barriers to fertility care.

A native of Montreal, Quebec – she is fluent in French and Greek.

Alongside her role as a fertility doctor, Dr. Korkidakis is a member of the American Society for Reproductive Medicine (ASRM), the New England Fertility Society (NEFS), the Pacific Coast Reproductive Society (PCRS), the Canadian Fertility and Andrology Society (CFAS), and the American College of Obstetricians and Gynecologists (ACOG).

“As a former reproductive fellow at Beth Israel Deaconess Medical Center and Boston IVF – we know firsthand the talent and expertise that Dr. Korkidakis brings to our Boston IVF fertility treatment team and are thrilled to have her join us.,” said David Stern, CEO of Boston IVF.

The Beth Israel Deaconess Medical Center/Boston IVF Reproductive Endocrinology and Infertility (REI) Fellowship program is amongst the most prestigious and intensive in the world, equipping fertility doctors with superior training, research, and empathy to help their patients build a family through assisted reproductive technology.

“To join Boston IVF and have the unique opportunity to work alongside such esteemed mentors is truly a great honor,” said Ann Korkidakis, MD. “I look forward to continuing in my role as a trusted resource for my patients in Waltham, Worcester, and across the state of Massachusetts.”

Double-board certified in OB/GYN and REI, Dr. Korkidakis earned her medical degree at McGill University, completed her residency in Obstetrics and Gynecology at Queen’s University, and received her fellowship in Reproductive Endocrinology at both the University of British Columbia in Vancouver and Beth Israel Deaconess Medical Center/Harvard Medical School in conjunction with Boston IVF.

Boston IVF’s Waltham Fertility Center offers a full array of reproductive treatment and care, including on-site andrology and embryology (IVF) laboratories, blood and ultrasound cycle monitoring, male infertility testing, IUI, IVF, egg freezing, and more.

Boston IVF’s Worcester Fertility Center offers a variety of services, including consultations, intrauterine inseminations (IUI), semen analysis, and blood/ultrasound monitoring.

To learn more about Dr. Korkidakis, to receive fertility treatment advice, or to schedule a consultation, visit Boston IVF’s website.

Follow Boston IVF on Instagram

Follow Boston IVF on Linkedin

Follow Boston IVF on Facebook

Follow Boston IVF on Twitter

ABOUT BOSTON IVF

Boston IVF is one of the largest and most experienced fertility networks in the United States, with more than 150,000 babies born since 1986. Founded as one of the nation’s first private practice IVF centers, the Boston IVF network has grown to include over 30 reproductive endocrinologists across 30 centers throughout Massachusetts, Maine, Massachusetts, Rhode Island, New York, Delaware, Idaho, Indiana, North Carolina, Ohio, and Utah. A renowned innovator of reproductive technologies, advanced protocols, and cutting-edge research, Boston IVF has achieved numerous “firsts” in reproductive care. Its scientific and research arm continues to pave the way for breakthroughs in fertility care and its accredited REI Fellowship Program has graduated numerous reproductive endocrinologists as part of its mission to train the next generation of fertility experts.

Media Contact

Zoe Marzi, Boston IVF, 1 781-434-6515, [email protected], https://www.bostonivf.com/

Theo Lopreste, Boston IVF, 1 781-434-6451, [email protected], https://www.bostonivf.com/

Twitter

SOURCE Boston IVF



Health: Psychology

Kvikna Medical Receives European Union MDR Certification

Leave a comment


Regulation MDR (EU) 2017/745 replaces the former European Medical Device Directive (93/42/EEC). The new Regulation describes the requirements and conformity assessment procedures that must be met before medical devices are introduced into the European Economic Area. It was established to set EU-wide rules to improve the safety and quality of medical devices, as well as transparency for patients to protect public health and patient safety. Kvikna Medical’s completion of the new process prior to the extended 2028 deadline helps to ensure the EU market has timely access to new products from the company.

“Stratus EEG is one of the first clinical EEG products to receive MDR certification and we are very proud of this accomplishment”, said Gardar Thorvardson, CEO of Kvikna Medical. “Gaining MDR approval now is a testament to the strength of the company’s quality and risk management systems and the overall caliber of our products. Kvikna Medical is highly committed to excellence in its products and internal processes and always strives to achieve the highest standards. In addition to MDR, the company also has ISO13485 and 14971 certifications.”

To learn more about Stratus EEG software and Kvikna Medical, visit www.stratusEEG.com.

About Kvikna Medical

Kvikna Medical was founded in 2008 to develop and market new and innovative EEG solutions and to make EEG monitoring more accessible to both clinicians and patients. The Stratus EEG™ software is used by thousands of neurologists across the globe to help diagnose and treat people with neurological disorders. Kvikna Medical is a division of Stratus, a privately held company and the largest provider of EEG solutions in the United States.

Media Contact

Jennifer Armstrong, Stratus, 1 9727438992, [email protected], www.stratuseeg.com

SOURCE Stratus

Health: Addiction

Med Schools Fear Board Exam Changes Could Impede Diversity and MD Preparedness

Leave a comment


In January 2022, officials transitioned USMLE Step 1 to a pass/fail model largely to reduce student’s stress and anxiety. However, many educators are not in favor of this change, and residency program directors feel they no longer have a clear, objective way to assess students’ applications for residency. Additionally, the overall USMLE Step 1 pass rates dipped from 88% in 2021 to 82% in 2022. 2

To understand how this change is impacting educators and the students they teach, TrueLearn, a leader in healthcare education whose platform blends data analytics with cognition science to optimize learning outcomes for the medical education community, conducted a survey of more than 250 medical school faculty members, primarily in the U.S. Participants were from institutions such as Duke University School of Medicine, University of California, Los Angeles (UCLA) School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, and University of California San Francisco (UCSF) School of Medicine.

TrueLearn’s survey provides insight into questions like, how is the USMLE Step 1 transition affecting medical students? Is it relieving their stress and anxiety? Will a pass/fail model impede diversity? Will the change result in potentially less prepared and knowledgeable physicians? How are educators dealing with this switch?

Freely available for download, the survey revealed a number of issues and trends including the following:

  • Diversity, equity and inclusion (DEI) was a major concern cited throughout the survey, and 40% of participants believe students – especially those less privileged – will have a tougher time matching into their top choices for residency.
  • Less than half of respondents believe the change will have any positive impact on students’ mental health and well-being.
  • More than half of respondents indicated that 5% or more of their medical students undergo formal remediation or delays each year. When asked if they have the data necessary to identify at-risk students, just 26% of participants stated “yes.”

“Making USMLE pass/fail has been catastrophic to the quality of physicians we are producing and we now only accept applicants from top 10 medical schools. It limits diversity and upward mobility,” wrote one survey participant. “The challenges are immense.”

TrueLearn’s Chief Commercial Officer, Kate Campbell, says, “TrueLearn aims to address these challenges through technology and collaboration. Our goal is to continually innovate technologies and tools that enable educators to understand their students’ strengths and weaknesses and, if necessary, put measures in place to ensure they succeed on their board exams and in their medical career. Vendors, educators, and policymakers must work together to ensure positive outcomes for all medical students and ultimately the patients they treat.”

About TrueLearn

TrueLearn is a leading digital learning and analytics company that focuses on training healthcare professionals in the areas of medicine, nursing, therapy, and allied health. Preparing for high-stakes exams in healthcare is challenging for even the highest performing learners. We help them realize their full potential and support institutions in meeting educational goals. Learn more about TrueLearn here.

1 The Match National Resident Matching Program. Results of the 2021 NRMP Program Director Survey. Nrmp.org. Accessed on August 14, 2023.

2 United States Medical Licensing Examination. Early Release of USMLE Step 1 2022 Summary Performance. USMLE.org. Accessed on August 14, 2023.

Media Contact

Marty Mullarkey, TrueLearn, 650-740-3841, [email protected], www.truelearn.com

Twitter

SOURCE TrueLearn



Health

Finance & Investing Announces Top 25 CFOs in Biotechnology for 2023

Leave a comment


Finance and Investing is pleased to announce The Top 25 CFOs in Biotechnology for 2023

NEW YORK, Aug. 23, 2023 /PRNewswire-PRWeb/ — Finance and Investing is pleased to announce The Top 25 CFOs in Biotechnology for 2023. Biotechnology, tracing back to ancient practices like bread, beer, and wine fermentation, experienced notable growth in the 19th century through advancements like the understanding of microorganisms and Gregor Mendel’s genetic studies. Major figures such as Pasteur and Lister contributed significantly to developments in fermentation and microbial processes. This eventually led to the emergence of prominent medical companies like Gilead Sciences, Amgen, Biogen Idec, and Celgene, contributing to a global biotechnology market estimated at $1.37 trillion in 2022. On top of that, projections show a predicted compound annual growth rate (CAGR) of 13.96% from 2023 to 2030, underscoring the potential for today’s biotech executives to effect meaningful change by bridging scientific innovation and business acumen, thereby catalyzing advancements in healthcare, agriculture, and other critical domains.

An excellent illustration of the advantages that come from combining business and scientific expertise can be seen in Mike Gutch, who holds the position of CFO at Noema Pharma. With both an MBA and a doctorate in cellular and molecular pathology, Gutch has built a substantial career overseeing financial matters for prominent companies in the field of biotechnology. His experience includes financial leadership roles at Entasis Therapeutics and AstraZeneca’s Corporate Development group. Similarly, Marisa Frackman holds the role of CFO at Sapience Therapeutics and boasts a wealth of expertise as a seasoned financial leader, spanning 18 years within the biotechnology capital markets arena. Her career commenced on Wall Street as a member of the Healthcare Investment Banking group at Deutsche Bank Securities. From there, she managed over 250 equity offerings, collectively generating more than $90 billion in funds. Finally, Ryan Jones, who serves as CFO at Kyverna Therapeutics, also contributes an extensive background in the domains of healthcare and life sciences. Notably, Jones holds credit as a co-inventor for five granted patents in the fields of biosensors and DNA sequencing. His involvement extends to serving as a Board Observer for several companies established by GE Ventures, including Menlo Microsystems, Vineti, Drawbridge Health, and Evidation Health.

Please join us in celebrating the accomplishments of The Top 25 CFOs in Biotechnology for 2023.

Alex Garini (Fresenius Kabi USA), Sue Hohenleitner (Johnson & Johnson), Bob Funck (Abbott), John McKenna (Novartis), Patrick Still (Pfizer), Carlos Santos (AstraZeneca), Caroline Litchfield (Merck), Sherry Davis (Eli Lilly and Company), Matt Symonds (Takeda), Zvi Albert (SUN PHARMA US), Andrew Dickinson (Gilead Sciences), Thomas Castellano (Abzena), Marc Belsky (Kezar Life Sciences), Glenn Whaley (Immunic Therapeutics), Ryan Jones (Kyverna Therapeutics), Patricia Dalfo (Hanford Pharmaceuticals), Tony Cords (Quincy Bioscience), Michael Gutch (Noema Pharma), Jon Nunez (Canopy Biosciences), Larry Dalesandro (Genus Lifesciences Inc.), Todd Knapp (Innovive), Noah Clauser (Astria Therapeutics, Inc.), Marisa Frackman (Sapience Therapeutics, Inc.), Rob Middlebrook (Cerevance), and Tiago Girao (Proteovant Therapeutics).

To view the full list, visit https://financeandinvesting.com/the-top-25-cfos-in-biotechnology-for-2023/

About Finance & Investing

Finance & Investing is a comprehensive source for research and information, business news, and corporate actions related to investment banking, wealth management and the public and private markets. The firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on finance and investing and the various firms and executives that make up the sector. Finance & Investing and its affiliates circulate its content to over 38,000 individuals and businesses.

Media Contact

Editor, Finance & Investing, 1 609-365-7014, [email protected], https://financeandinvesting.com/

SOURCE Finance & Investing